23andMe's share price is not doing too well, but they have the genetic information of 12 million people. There's probably a dollar value for any one person's DNA, and it seems like the share price might get there. Today the market cap is 220 million, so about 18USD per genome. That's not a whole lot.
This market resolves YES if at any time the company 23andme gets sold to another company or merges with a company bigger than themselves in market capitalisation before the end of 2025. Otherwise it resolves no if 23andme goes bankrupt or on 1 Jan 2026.
Stock prices: https://finance.yahoo.com/quote/ME/
About page saying they've sold 12M DNA kits: https://www.23andme.com/en-int/about/
Update 2025-07-01 (PST) (AI summary of creator comment): In response to a proposed purchase of 23andMe's assets out of bankruptcy, the creator has stated they will wait for the actual purchase to be completed before resolving.
Update 2025-07-19 (PST) (AI summary of creator comment): In response to the acquisition of 23andMe's assets out of bankruptcy, the creator will wait until the end of 2025 to resolve the market, awaiting further information.
1,000
3.00https://investors.23andme.com/node/10501/pdf
TTAM Research Institute... today announced that it has completed the acquisition of the Personal Genome Service (PGS) and Research Services business lines of 23andMe Holding Co. (together with its debtor subsidiaries, the “Company”) (OTC: MEHCQ), a genetics-led consumer healthcare company, under Section 363 of the U.S. Bankruptcy Code.
I'm honestly unsure how this should resolve given the criteria. I believe 23andMe went bankrupt, then was sold to TTAM. Chronologically, this probably should resolve NO, but spirit-of-the-title probably should resolve YES.
o3 thinks YES: https://chatgpt.com/share/68787caa-4a38-8011-9a40-e6e9f854e8a1
@Sketchy I'm inclined to wait until the end of 2025 in the hopes that more information comes out that makes it (more) clear
On June 27, 2025, the U.S. Bankruptcy Court for the Eastern District of Missouri approved the proposed purchase of all of the assets of 23andMe by TTAM Research Institute (“TTAM”), and we anticipate that the sale will close on or as soon as reasonably practicable after July 8, 2025.
TTAM is a nonprofit medical research organization founded by Anne Wojcicki (Co-Founder and former CEO of 23andMe).
@BoydKane Wait I'm not actually sure this should resolve YES. The market criteria says it resolves YES if the company is sold, but I think the deal is only for the assets to be sold and the company itself is getting dissolved under Chapter 11. Seems like under a literal reading of the market criteria that might be a no?
@Sketchy fair, I'm going to wait for something to actually happen before closing the market (and will send a comment if it looks unclear)
Published 09/30/2024:
(Reuters) - Genetic testing firm 23andMe Chief Executive Officer Anne Wojcicki would no longer be open to considering third-party takeover proposals for the company, a regulatory filing showed on Monday.
"It has become even clearer to me that the best path forward for the (company) is for me to take the company private," Wojcicki said.